Comparative study between methadone and buprenorphine-naloxone treatment in patients diagnosed of opioid use disorder

2018 ◽  
Author(s):  
María Nuria Ferrer Chinchilla ◽  
Jesús Payo Ollero ◽  
Francisco Ignacio Mata Cala
Keyword(s):  
Comparative Study ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Naloxone Treatment

Patterns of patient discontinuation from buprenorphine/naloxone treatment for opioid use disorder: A study of a commercially insured population in Massachusetts

2021 ◽  
pp. 108416
Author(s):  
Mahmudul Hasan ◽  
Noor-E-Alam ◽  
Prathamesh Mohite ◽  
Saiful Islam ◽  
Alicia Sasser Modestino ◽  
...  
Keyword(s):  
Opioid Use Disorder ◽  
Opioid Use ◽  
Naloxone Treatment

scholarly journals Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids

2019 ◽  
Vol 72 ◽  
pp. 160-168 ◽  
Author(s):  
Joshua A. Barocas ◽  
Jake R. Morgan ◽  
David A. Fiellin ◽  
Bruce R. Schackman ◽  
Golnaz Eftekhari Yazdi ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hepatitis C ◽  
Clinical Care ◽  
Opioid Use Disorder ◽  
Opioid Use ◽  
Naloxone Treatment

scholarly journals Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population

Medical Care ◽  
2017 ◽  
Vol 55 (7) ◽  
pp. 669-676 ◽  
Author(s):  
Brendan Saloner ◽  
Matthew Daubresse ◽  
G. Caleb Alexander
Keyword(s):  
Opioid Use Disorder ◽  
Opioid Use ◽  
Naloxone Treatment

L'esperienza clinica con Levometadone nel trattamento del disturbo da uso di oppiacei

MISSION ◽  
2019 ◽  
pp. 54-57
Author(s):  
Marco Riglietta ◽  
Paolo Donadoni ◽  
Grazia Carbone ◽  
Caterina Pisoni ◽  
Franca Colombi ◽  
...  
Keyword(s):  
Adverse Events ◽  
Real Life ◽  
Opioid Use Disorder ◽  
Racemic Mixture ◽  
Opioid Use ◽  
The Real ◽  
New Formulation

In Italy, at the end of the 1970s, methadone hydrochloride was introduced for the treatment of opioid use disorder, in the form of a racemic mixture consisting of levomethadone and dextromethadone.In 2015 Levometadone was introduced, a new formulation marketed in Italy for the treatment of opioid use disorder in 2015.The article aims to bring the experience of an Italian Addiction Centre back to the use of this new formulation in the "real life" analyzing the efficacy, the trend of adverse events and pharmacological iterations in a context in which the treated population often uses besides the opiates, cocaine and alcohol, are burdened by a relevant physical and psychic comorbidity and frequently have a prescribed polypharmacy.

Sign in / Sign up

Export Citation Format

Share Document